VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $2.79M invested in VistaGen Therapeutics in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$823K
2
+$21K
3
+$16K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.93K

Top Sellers

1
-$48K
2
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.69M
2
$441K
3
$221K
4
$157K
5
$72K
6
$65K
7
$48K
8
$32K
9
$21K
10
$17K
11
$16K
12
$2K
13
–
14
–